This study is currently not recruiting participants.

A MULTICENTER OPEN-LABEL LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY

  • STATUS
    Not Recruiting
Updated on 19 February 2024

Summary

ARC008 is an open-label, international, long-term safety extension study for eligible subjects who have participated in one of the following Aimmune AR101 clinical studies: ARC002, ARC004, ARC007, ARC010, ARC011, or any future clinical trial of AR101 that identifies ARC008 as a potential post-study option in the protocol. The rationale for conducting ARC008 is 4-fold: - To allow subjects who received placebo in Aimmune sponsored clinical studies with AR101 to receive active drug product - To allow subjects who received AR101 in Aimmune sponsored clinical studies to continue treatment until commercially available - To assess AR101's safety and tolerability over an extended period of dosing - To explore whether the level of desensitization to peanut is maintained or even continues to increase after a prolonged duration of dosing.

Description

ARC008 is an open-label, international, long-term safety extension study for eligible subjects who have participated in one of the following Aimmune AR101 clinical studies: ARC002, ARC004, ARC007, ARC010, ARC011, or any future clinical trial of AR101 that identifies ARC008 as a potential post-study option in the protocol. The rationale for conducting ARC008 is 4-fold: - To allow subjects who received placebo in Aimmune sponsored clinical studies with AR101 to receive active drug product - To allow subjects who received AR101 in Aimmune sponsored clinical studies to continue treatment until commercially available - To assess AR101's safety and tolerability over an extended period of dosing - To explore whether the level of desensitization to peanut is maintained or even continues to increase after a prolonged duration of dosing.

Details
Age 100years or below
Clinical Study IdentifierTX8491
Last Modified on19 February 2024

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.